ArticleFuture oncology (London, England)2025
Matching-adjusted indirect comparison of selpercatinib and pralsetinib in
Maximilian Hochmair et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
this papercites it